{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:04:01Z","timestamp":1793379841019,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010451","name":"Health and Family Planning Commission of Hunan Province","doi-asserted-by":"publisher","award":["W20243107"],"award-info":[{"award-number":["W20243107"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403495"],"award-info":[{"award-number":["82403495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.phrs.2026.108095","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:43:00Z","timestamp":1768030980000},"page":"108095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The TET\/5hmC mediated epigenetic landscape in glioma: From molecular mechanisms to therapeutic targeting and future perspectives"],"prefix":"10.1016","volume":"224","author":[{"given":"Jiarong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-8299","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108095_bib1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108095_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108095_bib3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108095_bib4","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1101\/gad.179184.111","article-title":"Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation","volume":"25","author":"Wu","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2026.108095_bib5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nature09303","article-title":"Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification","volume":"466","author":"Ito","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsmb.2372","article-title":"5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary","volume":"19","author":"Khare","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib7","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1093\/nar\/gkr120","article-title":"Genomic mapping of 5-hydroxymethylcytosine in the human brain","volume":"39","author":"Jin","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108095_bib8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1349-7006.2012.02213.x","article-title":"Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation","volume":"103","author":"Kudo","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib10","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.108095_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041036","article-title":"Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma","volume":"7","author":"Orr","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108095_bib12","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/hmg\/ddy214","article-title":"Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma","volume":"27","author":"Fernandez","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2026.108095_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.621460","article-title":"The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas","volume":"12","author":"Bragiel-Pieczonka","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108095_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature19081","article-title":"Tumour hypoxia causes DNA hypermethylation by reducing TET activity","volume":"537","author":"Thienpont","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-021-00857-0","article-title":"Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications","volume":"7","author":"Lopez-Bertoni","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2026.108095_bib16","article-title":"NSUN5\/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion","volume":"121","author":"Wu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108095_bib17","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.18632\/oncotarget.13719","article-title":"Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108095_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.32520","article-title":"Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis","volume":"146","author":"Carella","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2026.108095_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2051-5960-2-59","article-title":"Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma","volume":"2","author":"Ahsan","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.phrs.2026.108095_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.celrep.2014.08.071","article-title":"5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex","volume":"9","author":"Takai","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1101\/gr.136184.111","article-title":"ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia","volume":"22","author":"Landt","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.phrs.2026.108095_bib22","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1093\/nar\/gkx435","article-title":"A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer","volume":"45","author":"Good","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108095_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ajpath.2012.04.017","article-title":"Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas","volume":"181","author":"Muller","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2026.108095_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.molcel.2016.10.030","article-title":"Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development","volume":"64","author":"Zhang","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcell.2019.00099","article-title":"The human TET2 gene contains three distinct promoter regions with differing tissue and developmental specificities","volume":"7","author":"Lou","year":"2019","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.celrep.2015.12.044","article-title":"Tet3 Reads 5-Carboxylcytosine through Its CXXC Domain and Is a Potential Guardian against Neurodegeneration","volume":"14","author":"Jin","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13148-021-01156-9","article-title":"DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker","volume":"13","author":"Azizgolshani","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.phrs.2026.108095_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13177","article-title":"5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108095_bib29","article-title":"5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib34","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41388-019-1134-6","article-title":"Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells","volume":"39","author":"Herrmann","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.108095_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","article-title":"The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation","volume":"13","author":"Song","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib36","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108095_bib37","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s41598-018-19806-z","article-title":"Interplay between TETs and microRNAs in the adult brain for memory formation","volume":"8","author":"Kremer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib38","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3109\/21691401.2015.1111237","article-title":"Different expression of miR-29b and VEGFA in glioma","volume":"44","author":"Liu","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108095_bib39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/cas.14002","article-title":"AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma","volume":"110","author":"Ren","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib40","doi-asserted-by":"crossref","first-page":"25922","DOI":"10.18632\/oncotarget.25406","article-title":"Epigenetic dysregulation of TET2 in human glioblastoma","volume":"9","author":"Garcia","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108095_bib41","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMc090593","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Ducray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108095_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.celrep.2018.03.107","article-title":"A Distinct DNA methylation shift in a subset of glioma CpG island methylator phenotypes during tumor recurrence","volume":"23","author":"de Souza","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib44","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1111\/febs.15695","article-title":"Oxygen regulation of TET enzymes","volume":"288","author":"Matuleviciute","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2026.108095_bib45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","article-title":"Hypoxia induces production of L-2-hydroxyglutarate","volume":"22","author":"Intlekofer","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108095_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trecan.2017.12.005","article-title":"Metabolism, activity, and targeting of D- and L-2-Hydroxyglutarates","volume":"4","author":"Ye","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.phrs.2026.108095_bib47","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/stem.2621","article-title":"Hypoxia-mediated epigenetic regulation of stemness in brain tumor cells","volume":"35","author":"Prasad","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2026.108095_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00018-022-04396-x","article-title":"Mechanisms that regulate the activities of TET proteins","volume":"79","author":"Joshi","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7150\/jca.12010","article-title":"Genetic characterization of ten-eleven-translocation methylcytosine dioxygenase alterations in human glioma","volume":"6","author":"Kraus","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2026.108095_bib50","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1074\/jbc.M114.605881","article-title":"Phosphorylation of TET proteins is regulated via O-GlcNAcylation by the O-linked N-acetylglucosamine transferase (OGT)","volume":"290","author":"Bauer","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108095_bib51","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/nar\/gkz1144","article-title":"Phosphorylation of Tet3 by cdk5 is critical for robust activation of BRN2 during neuronal differentiation","volume":"48","author":"Rao","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108095_bib52","doi-asserted-by":"crossref","first-page":"20776","DOI":"10.1074\/jbc.M113.460386","article-title":"Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells","volume":"288","author":"Shi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108095_bib53","article-title":"SIRT1 deacetylates TET2 and promotes its ubiquitination degradation to achieve neuroprotection against Parkinson's disease","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2026.108095_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112889","article-title":"Exploring the multi-faceted role of sirtuins in glioblastoma pathogenesis and targeting options","volume":"23","author":"Kunadis","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.phrs.2026.108095_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2026.108095_bib57","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1186\/1471-2164-11-701","article-title":"DNA methylation in glioblastoma: impact on gene expression and clinical outcome","volume":"11","author":"Etcheverry","year":"2010","journal-title":"BMC Genom."},{"key":"10.1016\/j.phrs.2026.108095_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41568-023-00619-w","article-title":"Epigenetic lesions drive gliomagenesis","volume":"23","author":"Brewer","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2026.108095_bib59","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.1073\/pnas.1708914114","article-title":"Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1","volume":"114","author":"Mazor","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108095_bib60","article-title":"Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108095_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13059-018-1420-6","article-title":"Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues","volume":"19","author":"Zhou","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111780","article-title":"5-Hydroxymethylcytosine: far beyond the intermediate of DNA demethylation","volume":"25","author":"Zheng","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib63","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jmb.2019.07.039","article-title":"Protein interactions at oxidized 5-methylcytosine bases","volume":"432","author":"Pfeifer","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib64","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1074\/jbc.RA118.001785","article-title":"Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA","volume":"293","author":"Liu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108095_bib65","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/0008-5472.CAN-11-1157","article-title":"Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1","volume":"71","author":"Zhu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2026.108095_bib66","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/nar\/gkh739","article-title":"Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2)","volume":"32","author":"Valinluck","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108095_bib67","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1038\/s41467-020-18729-6","article-title":"Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation","volume":"11","author":"Lan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108095_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00018-024-05261-9","article-title":"Dynamic changes in RNA m(6)A and 5 hmC influence gene expression programs during macrophage differentiation and polarisation","volume":"81","author":"Pinello","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1158954","article-title":"The Tet2-Upf1 complex modulates mRNA stability under stress conditions","volume":"14","author":"Xia","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.phrs.2026.108095_bib70","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.gpb.2022.05.005","article-title":"Dynamic DNA 5-hydroxylmethylcytosine and RNA 5-methycytosine Reprogramming During Early Human Development","volume":"21","author":"Han","year":"2023","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.phrs.2026.108095_bib71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suva","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib72","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1016\/j.molcel.2023.11.003","article-title":"SRSF2 plays an unexpected role as reader of m(5)C on mRNA, linking epitranscriptomics to cancer","volume":"83","author":"Ma","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2026.108095_bib73","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1172\/JCI129317","article-title":"Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy","volume":"129","author":"Xu","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2026.108095_bib74","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.celrep.2015.03.020","article-title":"TET3 is recruited by REST for context-specific hydroxymethylation and induction of gene expression","volume":"11","author":"Perera","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038486","article-title":"REST controls self-renewal and tumorigenic competence of human glioblastoma cells","volume":"7","author":"Conti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2026.108095_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110244","article-title":"Vitamin D receptor, STAT3, and TET2 cooperate to establish tolerogenesis","volume":"38","author":"Catala-Moll","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib77","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/emboj.2012.357","article-title":"TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS","volume":"32","author":"Deplus","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108095_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105235","article-title":"O-GlcNAc transferase promotes glioblastoma by modulating genes responsible for cell survival, invasion, and inflammation","volume":"299","author":"Sheikh","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108095_bib79","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1093\/nar\/gky347","article-title":"Sin3a-Tet1 interaction activates gene transcription and is required for embryonic stem cell pluripotency","volume":"46","author":"Zhu","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2026.108095_bib80","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1093\/nar\/gkac642","article-title":"TET1 regulates gene expression and repression of endogenous retroviruses independent of DNA demethylation","volume":"50","author":"Stolz","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2026.108095_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-8-r91","article-title":"Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells","volume":"14","author":"Neri","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib82","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature09934","article-title":"Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells","volume":"473","author":"Wu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib83","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.canlet.2014.11.003","article-title":"EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma","volume":"356","author":"Zhang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108095_bib84","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41374-022-00741-7","article-title":"The epigenetic dysfunction underlying malignant glioma pathogenesis","volume":"102","author":"Dharmaiah","year":"2022","journal-title":"Lab Invest"},{"key":"10.1016\/j.phrs.2026.108095_bib85","first-page":"1","article-title":"Glial progenitors as targets for transformation in glioma","volume":"121","author":"Ilkhanizadeh","year":"2014","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.phrs.2026.108095_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112883","article-title":"Mutant IDH in gliomas: role in cancer and treatment options","volume":"15","author":"Solomou","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2026.108095_bib87","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.18632\/oncotarget.1412","article-title":"Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine","volume":"4","author":"Turcan","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108095_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng.3457","article-title":"Integrated genomic characterization of IDH1-mutant glioma malignant progression","volume":"48","author":"Bai","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.phrs.2026.108095_bib89","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2026.108095_bib90","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.1007\/s13277-015-3606-9","article-title":"Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma","volume":"36","author":"Kraus","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.phrs.2026.108095_bib91","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083845","article-title":"MGMT-methylation in non-neoplastic diseases of the central nervous system","volume":"22","author":"Teuber-Hanselmann","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/diseases12070163","article-title":"Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1-Deleted Cancer Cells","volume":"12","author":"Laranjeira","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.phrs.2026.108095_bib94","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/15592294.2019.1700004","article-title":"DNA hydroxymethylation increases the susceptibility of reactivation of methylated P16 alleles in cancer cells","volume":"15","author":"Li","year":"2020","journal-title":"Epigenetics"},{"key":"10.1016\/j.phrs.2026.108095_bib95","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.18632\/oncotarget.3330","article-title":"D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108095_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13578-023-00960-5","article-title":"Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes","volume":"13","author":"Shi","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phrs.2026.108095_bib97","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1111\/cas.15165","article-title":"Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model","volume":"112","author":"Nguyen","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib98","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/s41467-025-56781-2","article-title":"D-2-hydroxyglutarate impairs DNA repair through epigenetic reprogramming","volume":"16","author":"Lang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108095_bib99","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s00018-019-03335-7","article-title":"Tet3 regulates cellular identity and DNA methylation in neural progenitor cells","volume":"77","author":"Santiago","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib100","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.neuron.2024.10.012","article-title":"Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence","volume":"112","author":"Xie","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108095_bib101","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2026.108095_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202216","article-title":"The interaction between DNMT1 and high-mannose CD133 maintains the slow-cycling state and tumorigenic potential of glioma stem cell","volume":"9","author":"Wei","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41420-020-0264-5","article-title":"Tet2-mediated epigenetic drive for astrocyte differentiation from embryonic neural stem cells","volume":"6","author":"He","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.phrs.2026.108095_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136867","article-title":"Different flavors of astrocytes: revising the origins of astrocyte diversity and epigenetic signatures to understand heterogeneity after injury","volume":"22","author":"Villarreal","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108095_bib105","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1021\/ja4028346","article-title":"Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals","volume":"135","author":"Yin","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2026.108095_bib106","first-page":"vdad009","article-title":"Tumor microenvironment in glioblastoma: Current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol Adv."},{"key":"10.1016\/j.phrs.2026.108095_bib107","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nov125","article-title":"Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions","volume":"18","author":"Agnihotri","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2026.108095_bib108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","article-title":"Metabolic regulation of epigenetics","volume":"16","author":"Lu","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108095_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100605","article-title":"Spectroscopic and in vitro investigations of Fe(2+) \/alpha-ketoglutarate-dependent enzymes involved in nucleic acid repair and modification","volume":"23","author":"Schmidl","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.phrs.2026.108095_bib110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature12362","article-title":"Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19032-8","article-title":"Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine","volume":"12","author":"Crake","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13148-025-01816-0","article-title":"TET2-mediated 5-hydroxymethylcytosine of TXNIP promotes cell cycle arrest in systemic anaplastic large cell lymphoma","volume":"17","author":"Yu","year":"2025","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.phrs.2026.108095_bib113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1620\/tjem.2023.J028","article-title":"MiR-10b-5p impairs TET2-mediated inhibition of PD-L1 transcription thus promoting immune evasion and tumor progression in glioblastoma","volume":"260","author":"Du","year":"2023","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib114","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.celrep.2019.09.013","article-title":"TET2 regulates the neuroinflammatory response in microglia","volume":"29","author":"Carrillo-Jimenez","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.immuni.2017.07.020","article-title":"The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression","volume":"47","author":"Pan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108095_bib116","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fimmu.2019.00210","article-title":"TET enzymes and 5hmC in adaptive and innate immune systems","volume":"10","author":"Lio","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2026.108095_bib117","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.175098","article-title":"TET2 promotes tumor antigen presentation and T cell IFN-gamma, which is enhanced by vitamin C","volume":"9","author":"Cheng","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.108095_bib118","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.celrep.2013.08.050","article-title":"An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis","volume":"5","author":"Cheng","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108095_bib119","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1093\/nar\/gkv653","article-title":"MicroRNA-29b\/Tet1 regulatory axis epigenetically modulates mesendoderm differentiation in mouse embryonic stem cells","volume":"43","author":"Tu","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2026.108095_bib120","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","article-title":"First-in-Human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma","volume":"25","author":"Allen","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2026.108095_bib121","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application","volume":"13","author":"Hu","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.phrs.2026.108095_bib122","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1021\/mp500815b","article-title":"Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide","volume":"12","author":"Cui","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2026.108095_bib123","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1158\/1535-7163.MCT-06-0022","article-title":"Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci","volume":"5","author":"Munshi","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2026.108095_bib124","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-020-01643-6","article-title":"The application of histone deacetylases inhibitors in glioblastoma","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2026.108095_bib125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt.2726","article-title":"Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins","volume":"31","author":"Maeder","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108095_bib126","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx601","article-title":"Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation","volume":"45","author":"Godecke","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2026.108095_bib127","doi-asserted-by":"crossref","first-page":"46545","DOI":"10.18632\/oncotarget.10234","article-title":"CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter","volume":"7","author":"Choudhury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108095_bib128","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4976","article-title":"CRISPR\/dCas9-Tet1-mediated DNA methylation editing","volume":"14","author":"Qian","year":"2024","journal-title":"Bio Protoc."},{"key":"10.1016\/j.phrs.2026.108095_bib129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10142-024-01455-3","article-title":"Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects","volume":"24","author":"Rajanathadurai","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.phrs.2026.108095_bib130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108095_bib131","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12957-024-03579-z","article-title":"Efficacy and safety of IDH inhibitors in IDH-mutated cancers: a systematic review and meta-analysis of 4 randomized controlled trials","volume":"22","author":"Cai","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.phrs.2026.108095_bib132","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib133","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41375-024-02246-2","article-title":"Management of isocitrate dehydrogenase 1\/2 mutated acute myeloid leukemia","volume":"38","author":"Fruchtman","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2026.108095_bib134","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acsmedchemlett.9b00509","article-title":"Vorasidenib (AG-881): a first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma","volume":"11","author":"Konteatis","year":"2020","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108095_bib135","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib136","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41591-022-02141-2","article-title":"Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial","volume":"29","author":"Mellinghoff","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib137","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2026.108095_bib138","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1073\/pnas.2002016117","article-title":"Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium","volume":"117","author":"Gonzalez-Carter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108095_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of beta-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2026.108095_bib140","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/0008-5472.CAN-14-3208","article-title":"Hypoxia Drives Breast Tumor Malignancy through a TET-TNFalpha-p38-MAPK Signaling Axis","volume":"75","author":"Wu","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2026.108095_bib141","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10066","article-title":"TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity","volume":"473","author":"Williams","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108095_bib142","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1101\/gr.239277.118","article-title":"TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells","volume":"29","author":"Rasmussen","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.phrs.2026.108095_bib143","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10555-025-10253-7","article-title":"Epigenetic drugs in cancer therapy","volume":"44","author":"Suraweera","year":"2025","journal-title":"Cancer Metastas.. Rev."},{"key":"10.1016\/j.phrs.2026.108095_bib144","article-title":"An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas","volume":"3","author":"Cai","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.phrs.2026.108095_bib145","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108095_bib146","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12967-024-05040-x","article-title":"Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches","volume":"22","author":"Lofiego","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108095_bib147","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163450","article-title":"Impact of epigenetic reprogramming on antitumor immune responses in glioma","volume":"133","author":"McClellan","year":"2023","journal-title":"J. Clin. Invest."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:02:29Z","timestamp":1773968549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":147,"alternative-id":["S1043661826000101"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108095","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TET\/5hmC mediated epigenetic landscape in glioma: From molecular mechanisms to therapeutic targeting and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108095"}}